Companies › LGND

LIGAND PHARMACEUTICALS INC (LGND)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000886163 · EDGAR filings · Updated 2026-07-22

LIGAND PHARMACEUTICALS INC (LGND) has reported institutional ownership of 103.7%, with 353 institutional managers holding positions valued at $4.15B per the latest 13F reporting period.

Filings this week (1)

• 2026-07-22 — Employee-plan registration (S-8) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-14 — Current report (8-K) filed
• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-06 — Insider transaction reported (Form 4)
• 2026-07-01 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LIGAND PHARMACEUTICALS INC has 353 institutional holders and institutional ownership of 103.7%.

Insider activity

Insiders reported 137 transactions (5 buys, 73 sells) across 10 reporting insiders, with a net reported value of −$9.64M.

Related companies

RADNET INC (RDNT) · IRHYTHM HOLDINGS INC (IRTC) · SPYRE THERAPEUTICS INC (SYRE) · Newamsterdam Pharma Co NV (NAMS) · SOTERA HEALTH CO (SHC) · INDIVIOR PHARMACEUTICALS INC (INDV)